Study details
Enrolling now
Endometriosis and Microvascular Dysfunction: Role of Inflammation
Penn State University
NCT IDNCT05069740ClinicalTrials.gov data as of Apr 2026
Phase
EARLY_PHASE1
Target enrollment
24
Study length
about 5 years
Ages
18–45
Sex
Female only
Locations
1 site in PA
What this study is about
Researchers are testing a treatment for endometriosis to see if it helps with microvascular dysfunction. The trial will measure inflammation and the LOX-1 receptor in women with endometriosis.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Placebo
- 2.Take Salsalate Pill
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Oral
How treatment is administered
Treatment Assignment
Randomized & Blinded
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Drug classes
NERVOUS SYSTEM
Drug routes
oral (Oral Tablet)
Endpoints
Primary: Biopsy LOX-1 protein expression, Sera LOX-1 protein expression
Secondary: sera cytokine expression analysis
Body systems
Reproductive Health